Valneva announces peer-reviewed publication on the global health and economic burden of chikungunya in the british medical journal

Saint-herblain (france), december 4, 2024 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announces the publication of an article on the global health and economic burden of mosquito-borne disease chikungunya in the british medical journal (bmj), one of the world's leading peer-reviewed medical journals.
VALN Ratings Summary
VALN Quant Ranking